BOOG 2024-03
Optimisation of treatment in low stage TNBC with high sTIL
BOOG 2024-02
E-monitoring of patient reported side effects
BOOG 2024-01
Symptom monitoring in metastatic breast cancer
BOOG 2024
Landelijk borstkanker cohort
BOOG 2023-02
Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse
BOOG 2023-01
Postoperative re-irradiation with and without hyperthermia
BOOG 2022-05
Imlunestrant vs Standard Adjuvant Endocrine Therapy
BOOG 2022-04
Personalized care and personalized surveillance
BOOG 2022-03
Alpelisib in PIK3CA-mutated HER2+ advanced breast cancer
BOOG 2022-02
De-escalating radiotherapy
BOOG 2022-01
Fasting Mimicking Diet
BOOG 2021-04
Dato-DXd Versus Investigator's Choice of Chemotherapy
